Combination of drugs promising for brain tumor treatment

Combination of drugs promising for brain tumor treatment
Results from a phase 1 clinical trial suggests that the immunotherapy drug and new precision drug work together to attack the tumor and reduce the cancer in some patients.
By
iStock
Story at a glance
Researchers are testing out a combination of two drugs as a treatment for an aggressive type of brain cancer called glioblastoma.
These drugs target the immune system and allow it to target the tumor.
A phase 1 clinical trial shows promising results from two patients.
Glioblastoma is a type of cancer that can form in the brain or spinal cord. The drugs used in the clinical trial are atezolizumab, an immunotherapy drug, and ipatasertib, a new precision drug that “may be able to uncloak tumours to the immune system,” according to a statement from the Institute of Cancer Research, London.

Related Keywords

United States , London , City Of , United Kingdom , America , Juanita Lopez , Institute Of Cancer Research , Food Drug Administration , Cancer Research , Clinical Researcher , Add Changing America , Drug Administration , Johann De Bono , Experimental Cancer Medicine , ஒன்றுபட்டது மாநிலங்களில் , லண்டன் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , அமெரிக்கா , வநீட லோபஸ் , நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி , புற்றுநோய் ஆராய்ச்சி , மருத்துவ ஆராய்ச்சியாளர் , ஜோஹான் டி போனோ , சோதனை புற்றுநோய் மருந்து ,